Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

Hims & Hers' lower-priced injectable semaglutide promoted during the Super Bowl has led to some patients receiving the more ...

Hims & Hers Health put out a jaw dropping commercial. Now, Hims stock is just dropping, as its semaglutide business faces a ...

Drinking artificially sweetened beverages may reduce metformin’s effectiveness in young patients with obesity and prediabetes ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...

Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing mobile clinical network ...

While one study found lower rates of preterm birth alongside higher rates of hypertensive disorders, another found fewer ...